My view: it’s dropped on barely any volume, see my chart above....

My view: it’s dropped on barely any volume, see my chart above. VWAP for the last 20 weeks is still 23.5 cents. They gave out a bunch of options at IPO that triggered on the FDA clearance and are being worked through now.

It was pushed down for a while after the FDA spike on the premise that there was a CR required, which has been done now. Moving forward I think there will be very limited supply, just needs some demand again. That should come on any revenue related announcement. I need to take a closer look at the Hapvida announcements over the last 12 months, but they kicked off a 12 month trial in Feb last year, and I believe they expanded it to include more units during the trial. If that is indeed ending this month there could be news on that soon.